Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Hamzaraj

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Cardiology|December 9, 2024
Early and Long-Term Outcomes of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention to the Left Main Coronary ArteryMohammad Abdelghani, Salma Taha, Osama Shoeib, et al.
International Journal of Cardiology|November 29, 2024
Association of ABO blood group with risk of coronary stent thrombosisCaglayan Demirel, Kevin Hamzaraj, Janina Fangl, et al.
International Journal of Molecular Sciences|November 13, 2025
Cardiac Circular RNAs CDR1as, Circ-RCAN2, Circ-C12orf29 Show Cell-Specific Hypoxia-Induced Dysregulation and Distinct In Vitro EffectsEna Hasimbegovic, Dominika Lukovic, Nina Kastner, et al.
Journal of Clinical Medicine|May 11, 2024
Low Bone Mineral Density on Computed Tomography: Association with Poor Survival after Transcatheter Aortic Valve ReplacementCaglayan Demirel, Kseniya Halavina, Kevin Hamzaraj, et al.
Heart & Lung : the Journal of Critical Care|November 14, 2024
Bone mineral density and TAVR outcome: A comparative analysis between patients with enhanced and non-enhanced TAVR CT scansCaglayan Demirel, Kevin Hamzaraj, Anna Seeber, et al.
Biomolecules|February 26, 2025
Circulating Autoantibodies Against Vasoactive Biomarkers Related to Orthostatic Intolerance in Long COVID Patients Compared to No-Long-COVID Populations: A Case-Control StudyEmilie Han, Katrin Müller-Zlabinger, Ena Hasimbegovic, et al.
Open Heart|October 18, 2024
Clinical development and proof of principle testing of new regenerative vascular endothelial growth factor-D therapy for refractory angina: rationale and design of the phase 2 ReGenHeart trialAleksi J Leikas, Juha E K Hartikainen, Jens Kastrup, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Cardiology|December 9, 2024
Early and Long-Term Outcomes of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention to the Left Main Coronary ArteryMohammad Abdelghani, Salma Taha, Osama Shoeib, et al.
International Journal of Cardiology|November 29, 2024
Association of ABO blood group with risk of coronary stent thrombosisCaglayan Demirel, Kevin Hamzaraj, Janina Fangl, et al.
International Journal of Molecular Sciences|November 13, 2025
Cardiac Circular RNAs CDR1as, Circ-RCAN2, Circ-C12orf29 Show Cell-Specific Hypoxia-Induced Dysregulation and Distinct In Vitro EffectsEna Hasimbegovic, Dominika Lukovic, Nina Kastner, et al.
Journal of Clinical Medicine|May 11, 2024
Low Bone Mineral Density on Computed Tomography: Association with Poor Survival after Transcatheter Aortic Valve ReplacementCaglayan Demirel, Kseniya Halavina, Kevin Hamzaraj, et al.
Heart & Lung : the Journal of Critical Care|November 14, 2024
Bone mineral density and TAVR outcome: A comparative analysis between patients with enhanced and non-enhanced TAVR CT scansCaglayan Demirel, Kevin Hamzaraj, Anna Seeber, et al.
Biomolecules|February 26, 2025
Circulating Autoantibodies Against Vasoactive Biomarkers Related to Orthostatic Intolerance in Long COVID Patients Compared to No-Long-COVID Populations: A Case-Control StudyEmilie Han, Katrin Müller-Zlabinger, Ena Hasimbegovic, et al.
Open Heart|October 18, 2024
Clinical development and proof of principle testing of new regenerative vascular endothelial growth factor-D therapy for refractory angina: rationale and design of the phase 2 ReGenHeart trialAleksi J Leikas, Juha E K Hartikainen, Jens Kastrup, et al.
Pageof 2